Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ICN Polfa Rzeszów is a prominent Polish pharmaceutical manufacturer based in Rzeszów, currently operating as a key production site for Bausch Health. Founded in 1951 as part of the state-owned Polfa union, the company was acquired by ICN Pharmaceuticals in 1997 and has since transitioned through the Valeant and Bausch Health corporate structures. The facility specializes in the production of a wide range of pharmaceutical forms, including tablets, ointments, and sterile drops, covering therapeutic areas such as dermatology, ophthalmology, and central nervous system disorders. It serves as a significant hub for both the domestic Polish market and international distribution, providing high-quality generic and branded medications. The site is recognized for its advanced manufacturing capabilities and adherence to international Good Manufacturing Practice standards.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ICN Polfa Rzeszow.